Volume 56, Issue 5, Pages (November 2009)

Slides:

Advertisements

Similar presentations

Volume 60, Issue 4, Pages (October 2011)

Advertisements

Volume 61, Issue 5, Pages (May 2012)

Volume 68, Issue 6, Pages (December 2015)

Volume 52, Issue 1, Pages (July 2007)

Volume 62, Issue 3, Pages (September 2012)

Volume 172, Issue 6, Pages (December 2004)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 58, Issue 2, Pages (August 2010)

Volume 58, Issue 1, Pages (July 2010)

Volume 63, Issue 2, Pages (February 2013)

Volume 55, Issue 2, Pages (February 2009)

Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi European Urology

Volume 62, Issue 4, Pages (October 2012)

Volume 58, Issue 1, Pages (July 2010)

Epidemiology and Risk Factors of Urothelial Bladder Cancer

Volume 61, Issue 5, Pages (May 2012)

Volume 53, Issue 4, Pages (April 2008)

Volume 68, Issue 3, Pages (September 2015)

Volume 52, Issue 3, Pages (September 2007)

Volume 51, Issue 3, Pages (March 2007)

Lymph Node Dissection in Renal Cell Carcinoma

Volume 54, Issue 4, Pages (October 2008)

Volume 66, Issue 3, Pages (September 2014)

Volume 56, Issue 3, Pages (September 2009)

Volume 63, Issue 4, Pages (April 2013)

Volume 60, Issue 4, Pages (October 2011)

Volume 66, Issue 3, Pages (September 2014)

Volume 67, Issue 4, Pages (April 2015)

Volume 59, Issue 2, Pages (February 2011)

Volume 63, Issue 1, Pages (January 2013)

Volume 66, Issue 2, Pages (August 2014)

Nomograms for Bladder Cancer

Precystectomy Nomogram for Prediction of Advanced Bladder Cancer Stage

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 67, Issue 2, Pages (February 2015)

Volume 52, Issue 5, Pages (November 2007)

Volume 55, Issue 2, Pages (February 2009)

Volume 52, Issue 1, Pages (July 2007)

Volume 57, Issue 4, Pages (April 2010)

Volume 60, Issue 5, Pages (November 2011)

International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia Brett Delahunt, John R. Srigley, Lars Egevad,

Volume 61, Issue 5, Pages (May 2012)

Volume 74, Issue 3, Pages (September 2018)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 62, Issue 2, Pages (August 2012)

Volume 59, Issue 1, Pages (January 2011)

Volume 60, Issue 6, Pages (December 2011)

Tyrosine Kinase Inhibitors in Clinical Practice: Patient Selection

Volume 53, Issue 1, Pages (January 2008)

Volume 50, Issue 5, Pages (November 2006)

Volume 52, Issue 6, Pages (December 2007)

Testicular Cancer Variations in Time and Space in Europe

Volume 53, Issue 1, Pages (January 2008)

Volume 49, Issue 4, Pages (April 2006)

Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi European Urology

Volume 63, Issue 2, Pages (February 2013)

Volume 54, Issue 4, Pages (October 2008)

Prognostic Impact of Comorbidity in Patients with Bladder Cancer

European Urology Oncology

Sergio Bracarda European Urology Supplements

European Urology is “Your” Journal

Bisphosphonates Can Prevent Skeletal Complications of Malignant Bone Disease from Prostate Cancer and Renal Cell Carcinoma Fred Saad European Urology.

Epidemiology of Renal Cell Carcinoma

Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature Liliana Vartolomei, Shahrokh F. Shariat, Mihai.

Volume 51, Issue 6, Pages (June 2007)

Volume 54, Issue 1, Pages (July 2008)

European Association of Urology Guidelines for Systemic Therapy in Metastatic Renal Cell Carcinoma: What is Recommended and Why? Jean-Jacques Patard

Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma Jan Roigas European Urology Supplements Volume.

Kaplan-Meier survival analysis for all-cause and CVD mortality in 2,823 type 2 diabetic patients stratified by CKD according to each creatinine-based equation.

How to Treat a Patient with T1 High-grade Disease and No Tumour on Repeat Transurethral Resection of the Bladder? Shahrokh Shariat, Paolo Gontero, James.

Presentation transcript:

Volume 56, Issue 5, Pages 775-781 (November 2009) A Proposal for Reclassification of the Fuhrman Grading System in Patients with Clear Cell Renal Cell Carcinoma Maxine Sun, Giovanni Lughezzani, Claudio Jeldres, Hendrik Isbarn, Shahrokh F. Shariat, Philippe Arjane, Hugues Widmer, Daniel Pharand, Mathieu Latour, Paul Perrotte, Jean-Jacques Patard, Pierre I. Karakiewicz European Urology Volume 56, Issue 5, Pages 775-781 (November 2009) DOI: 10.1016/j.eururo.2009.06.008 Copyright © 2009 Terms and Conditions

Fig. 1 Kaplan-Meier predicting cancer-specific mortality. (A) Cancer-specific mortality of all patients. (B) Cancer-specific mortality according to conventional four-tiered Fuhrman grading scheme. (C) Cancer-specific mortality according to the modified Zisman et al. two-tiered Fuhrman grading scheme. (D) Cancer-specific mortality according to Ficarra et al. three-tiered Fuhrman grading scheme. All individual log-rank p-values <0.001. European Urology 2009 56, 775-781DOI: (10.1016/j.eururo.2009.06.008) Copyright © 2009 Terms and Conditions